<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36602797</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021.</ArticleTitle><Pagination><StartPage>e2249710</StartPage><MedlinePgn>e2249710</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2249710</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.49710</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations.</AbstractText><AbstractText Label="OBJECTIVE">To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Any VDPV2 detection after completion of the supplementary immunization activities.</AbstractText><AbstractText Label="RESULTS">A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV-only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Chunxiang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Lixin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shuangli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qianli</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiajie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nan</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Liangshan Prefectural Center for Disease Control and Prevention, Liangshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Leibo County Center for Disease Control and Prevention, Liangshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaozhen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Liangshan Prefectural Center for Disease Control and Prevention, Liangshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Chinese Field Epidemiology Training Program, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Xianxiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Chinese Field Epidemiology Training Program, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Zhijie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodewald</LastName><ForeName>Lance E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huaqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiushun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Zundong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>China cVDPV2 Response Experts Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011054">Poliovirus Vaccine, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062065">Wastewater</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011054" MajorTopicYN="N">Poliovirus Vaccine, Inactivated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062065" MajorTopicYN="N">Wastewater</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Weizhong</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Qun</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luo</LastName><ForeName>Huiming</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Aiqiang</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36602797</ArticleId><ArticleId IdType="pmc">PMC9856606</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.49710</ArticleId><ArticleId IdType="pii">2800080</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sasaki A, Haraguchi Y, Yoshida H. Estimating the risk of re-emergence after stopping polio vaccination. Front Microbiol. 2012;3:178. doi:10.3389/fmicb.2012.00178</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00178</ArticleId><ArticleId IdType="pmc">PMC3390584</ArticleId><ArticleId IdType="pubmed">22783231</ArticleId></ArticleIdList></Reference><Reference><Citation>Estivariz CF, Kovacs SD, Mach O. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks. Vaccine. 2022;S0264-410X(22)00304-8. doi:10.1016/j.vaccine.2022.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.03.027</ArticleId><ArticleId IdType="pmc">PMC10389290</ArticleId><ArticleId IdType="pubmed">35365341</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health and Family Planning Commission of the People&#x2019;s Republic of China . Notification of stop using trivalent oral poliovirus live attenuated vaccine in China. April 28, 2016.</Citation></Reference><Reference><Citation>Na C, Wang D, Zhu S, et al. . Poliovirus neutralizing antibody levels among children associated with a circulating vaccine-derived poliovirus type II in Liangshan prefecture of Sichuan province in 2019. Chinese J Vaccine Immunization. 2022;28(2):140-144.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Q&amp;A with Michel Zaffran: cVDPV2 and the vaccine available to stop it. December 19, 2019. Accessed November 28, 2022. https://polioeradication.org/news-post/caught-between-a-rock-and-a-hard-place-cvdpv2-and-the-vaccine-available-to-stop-it/</Citation></Reference><Reference><Citation>McCarthy KA, Chabot-Couture G, Famulare M, Lyons HM, Mercer LD. The risk of type 2 oral polio vaccine use in post-cessation outbreak response. BMC Med. 2017;15(1):175. doi:10.1186/s12916-017-0937-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-017-0937-y</ArticleId><ArticleId IdType="pmc">PMC5627419</ArticleId><ArticleId IdType="pubmed">28974220</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Jorba J, Greene SA, et al. . Update on vaccine-derived poliovirus outbreaks&#x2014;worldwide, July 2019-February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(16):489-495. doi:10.15585/mmwr.mm6916a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6916a1</ArticleId><ArticleId IdType="pmc">PMC7188410</ArticleId><ArticleId IdType="pubmed">32324719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning W, Fan C, Yan D, et al. . The epidemiology characteristics analysis of vaccine-derived poliovirus and cases in China. Chinese J Vaccines Immunization. 2014;20(3):2001-2013.</Citation></Reference><Reference><Citation>Hovi T, Cantell K, Huovilainen A, et al. . Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet. 1986;1(8495):1427-1432. doi:10.1016/S0140-6736(86)91566-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(86)91566-7</ArticleId><ArticleId IdType="pubmed">2872526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins PC, Modlin JF. Decision analysis in planning for a polio outbreak in the United States. Pediatrics. 2006;118(2):611-618. doi:10.1542/peds.2005-2358</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-2358</ArticleId><ArticleId IdType="pubmed">16882814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Gao Z, Bai S, et al. . Immunogenicity and safety of Sabin-strain based inactivated poliovirus vaccine replacing Salk-strain based inactivated poliovirus vaccine: an innovative application of different strain-IPVs replacement. Vaccine. 2021;39(17):2467-2474. doi:10.1016/j.vaccine.2021.02.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.02.073</ArticleId><ArticleId IdType="pubmed">33810904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong-Lim AL, Shukarev G, Trinidad-Aseron M, et al. . Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6 cell line: a phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age. Hum Vaccin Immunother. 2022;18(5):2044255. doi:10.1080/21645515.2022.2044255</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2044255</ArticleId><ArticleId IdType="pmc">PMC9196784</ArticleId><ArticleId IdType="pubmed">35344464</ArticleId></ArticleIdList></Reference><Reference><Citation>De Coster I, Leroux-Roels I, Bandyopadhyay AS, et al. . Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. Lancet. 2021;397(10268):39-50. doi:10.1016/S0140-6736(20)32541-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32541-1</ArticleId><ArticleId IdType="pmc">PMC7811203</ArticleId><ArticleId IdType="pubmed">33308429</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Comprehensive outbreak response successfully stops spread of polio in Tajikistan. April 28, 2022. Accessed November 28, 2022. https://polioeradication.org/news-post/comprehensive-outbreak-response-successfully-stops-spread-of-polio-in-tajikistan/</Citation></Reference><Reference><Citation>Klapsa D, Wilton T, Zealand A, et al. . Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022;400(10362):1531-1538. doi:10.1016/S0140-6736(22)01804-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01804-9</ArticleId><ArticleId IdType="pmc">PMC9627700</ArticleId><ArticleId IdType="pubmed">36243024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill M, Pollard AJ. Detection of poliovirus in London highlights the value of sewage surveillance. Lancet. 2022;S0140-6736(22)01885-2. doi:10.1016/S0140-6736(22)01885-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01885-2</ArticleId><ArticleId IdType="pubmed">36243023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>